CISCRP - Center for Information & Study on Clinical Research Participation Healthcare Professional
about clinical research participation
Provide Education to Staff and Patient Volunteers
stay informed and involved in clinical research
learn more about CISCRP

Clinical Trial Facts & Figures for Health Professionals

View charts on Public Attitudes and Perceptions

Segmentation of US Clinical Trials by Therapeutic Area
Source: Parexel's Bio/Pharmaceutical R&D Statistical Sourcebook 2009/2010

 

Distribution of Delays in U.S. Site Enrollment Timelines
(Percent of Sites)

Distribution of Delays in U.S. Site Enrollment Timelines
Source: Parexel's Bio/Pharmaceutical R&D Statistical Sourcebook 2009/2010

top

Distribution of Delays in Site Enrollment Globally:
U.S., Europe, Latin America, and Asia Pacific
(Percent of Sites)

Distribution of Delays in Site Enrollment Globally: U.S., Europe, Latin America, and Asia Pacific
Source: Parexel's Bio/Pharmaceutical R&D Statistical Sourcebook 2009/2010

 

Time Consumed by Various Clinical Trial Activities
Source: Parexel's Bio/Pharmaceutical R&D Statistical Sourcebook 2009/2010

top

Recent Estimates of the Costs of Developing New Drugs
Source: Parexel's Bio/Pharmaceutical R&D Statistical Sourcebook 2009/2010

 

Segmentation of Active FDA-Regulated Clinical Trials for Drugs by Therapeutic Category
(based on active drug INDs as of year-end 2008)
% of Trials
% of Trials

Cardiovascular

6.5%

Neurology

9.4%

Psychiatry

5.2%

Anesthesia/Analgesia/Rheumatology

9.4%

Metabolism/Endocrine

7.4%

Pulmonary/Allergy

4.8%

Gastroenterology

5.5%

Dermatology/Dental

7.0%

Reproductive/Urologic

7.0%

Anti-infective/Ophthalmologic

7.6%

Antiviral

5.6%

Special Pathogens/Transplant

3.3%

Oncology

14.7%

Medical Imaging/Hematology

4.3%

Nonprescription Drugs

2.4%
   

Source: Parexel's Bio/Pharmaceutical R&D Statistical Sourcebook 2009/2010

 

Mean Cost per Patient in Clinical Trials by Clinical Phase, Worldwide, 2006-2008
Source: Parexel's Bio/Pharmaceutical R&D Statistical Sourcebook 2009/2010

top

Mean Patient Reimbursement Per Visit in Clinical Trials by Phase, Worldwide, 2006-2008
Source: Parexel's Bio/Pharmaceutical R&D Statistical Sourcebook 2009/2010

 

Mean Patient Reimbursement Per Visit in Clinical Trials by Therapeutic Area, Worldwide, 2006-2008
Source: Parexel's Bio/Pharmaceutical R&D Statistical Sourcebook 2009/2010

top

Index of Mean Cost per Patient in Clinical Trials by Clinical Phase, Worldwide, 2006-2008
Source: Parexel's Bio/Pharmaceutical R&D Statistical Sourcebook 2009/2010

Index of Mean Cost per Patient in Clinical Trials by Therapeutic Area, Worldwide, 2006-2008
Source: Parexel's Bio/Pharmaceutical R&D Statistical Sourcebook 2009/2010

top

Index of Mean Phase I Cost per Patient in Clinical Trials by Therapeutic Area, US, 2006-2008
Source: Parexel's Bio/Pharmaceutical R&D Statistical Sourcebook 2009/2010

Index of Mean Phase II Cost per Patient in Clinical Trials by Therapeutic Area, US, 2006-2008
Source: Parexel's Bio/Pharmaceutical R&D Statistical Sourcebook 2009/2010

top

Index of Mean Phase III Cost per Patient in Clinical Trials by Therapeutic Area, US, 2006-2008
Source: Parexel's Bio/Pharmaceutical R&D Statistical Sourcebook 2009/2010

Index of Mean Phase IV Cost per Patient in Clinical Trials by Therapeutic Area, US, 2006-2008
Source: Parexel's Bio/Pharmaceutical R&D Statistical Sourcebook 2009/2010

top